BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Wilex AG 

Grillparzerstrasse 10

81675 Munich  Bavaria    Germany
Phone: 49-0-89-41-31-38-0 Fax: 49-0-89-41-31-38-99


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Drug Discovery





 Company News
Wilex AG (WL6.DE) Nosedives As Company Cuts 80 Percent Of Workers 1/30/2014 7:44:53 AM    More...
Wilex AG (WL6.DE) Restructures, Cuts Jobs 12/5/2012 8:32:58 AM    More...
Wilex AG (WL6.DE)'s Kidney Cancer Drug Fails in Late Stage Trial 10/17/2012 8:27:10 AM    More...
Prometheus Laboratories Inc. Obtains Exclusive US Commercialization Rights for RENCAREX(R) from Wilex AG; Wilex to Receive $19 Million Upfront 5/2/2011 7:00:06 AM    More...
Wilex AG's Redectane(R) Meets Both Endpoints Specificity And Sensitivity With Superiority Over CT In Its Pivotal Phase III Trial 5/19/2010 8:11:03 AM    More...
UCB Group (UCBJF.PK) and Wilex AG to Enter into Strategic Alliance to Develop UCB's Preclinical Oncology Portfolio 1/9/2009 6:39:19 AM    More...
Wilex AG Closes A EUR 30 Million ($39 Million) Series C Private Equity Round 10/19/2005 5:10:22 PM    More...
14th Annual Report: Top 100 Biotechnology Companies 10/19/2005 5:09:32 PM    More...
Wilex AG Starts Patient Enrolment In Rencarex Pivotal Phase III Trial In Renal Cell Carcinoma 10/19/2005 5:08:45 PM    More...